Unique ID issued by UMIN | UMIN000023190 |
---|---|
Receipt number | R000026734 |
Scientific Title | Development of a risk scale for emergence agitation after general anesthesia in children |
Date of disclosure of the study information | 2016/07/15 |
Last modified on | 2016/07/15 18:06:50 |
Development of a risk scale for emergence agitation after general anesthesia in children
Development of a risk scale for emergence agitation after general anesthesia in children
Development of a risk scale for emergence agitation after general anesthesia in children
Development of a risk scale for emergence agitation after general anesthesia in children
Japan |
inguinal hernia, adenoid hypertrophy, tonsillar hypertrophy, unilateral strabismus, cryptorchidism, otitis media, and other minor surgeries
Anesthesiology | Child |
Others
NO
The goal of this two-phased study was 1) to determine predictors of EA after general anesthesia in children and develop an EA risk scale using the predictors with their logarithm of odds ratio in retrospective study (development phase), and 2) to confirm validity of the EA risk scale in the prospective cohort study (validation phase).
Others
The goal of this two-phased study was 1) to determine predictors of EA after general anesthesia in children and develop an EA risk scale using the predictors with their logarithm of odds ratio in retrospective study (development phase), and 2) to confirm validity of the EA risk scale in the prospective cohort study (validation phase).
Exploratory
Pragmatic
Not applicable
Development of the EA risk scale and confirmation its validity.
Observational
18 | months-old | < |
96 | months-old | >= |
Male and Female
We enrolled patients with ASA physical status I or II aged from 1.5 to 8 years who were scheduled to undergo general anesthesia. Operative procedures included inguinal hernia repair, adenoidectomy and/or tonsillectomy, unilateral strabismus surgery, cryptorchidism repair, tympanostomy tube insertion, and other minor surgeries.
We excluded patients who took psychotropic drugs or has mental retardation.
100
1st name | |
Middle name | |
Last name | Maai Hino |
Itabashi Chuo Medical Center
Department of Anesthesiology
Azusawa 2-12-7, Itabashi-ku, Tokyo, Japan
03-3967-1181
mhino0@yahoo.co.jp
1st name | |
Middle name | |
Last name | Takahiro Mihara |
Kanagawa Children's Medical Center
Department of Anesthesiology
Mutsukawa 2-138-4, Minami-ku, Yokohama, Japan
045-711-2351
miharaxxxtotoro@yahoo.co.jp
Kanagawa Children's Medical Center, Yokohama, Japan
Department of Anesthesiology
None
Self funding
NO
神奈川県立こども医療センター(神奈川県)
2016 | Year | 07 | Month | 15 | Day |
Unpublished
We developed the EA risk scale by using the data from the previous RCT in our hospital. The EA risk scale consisted of four domains; age, PAB score, operative procedure, and anesthesia time. In addition, the EA risk scale showed an excellent predictive performance (c-index > 0.8) in our validation cohort.
Completed
2014 | Year | 05 | Month | 01 | Day |
2014 | Year | 05 | Month | 01 | Day |
2016 | Year | 04 | Month | 01 | Day |
2016 | Year | 04 | Month | 07 | Day |
2016 | Year | 04 | Month | 07 | Day |
2016 | Year | 04 | Month | 07 | Day |
The EA risk score ranged from 1 to 23 points. The area under the ROC curve (i.e., the c-index) of the validation phase was 0.81 (95 % CI: 0.72-0.89). The best cut-off point was 11 (sensitivity = 87 %, and specificity = 61 %). The gray zone of the validation phase ranged from 10 to 13 points in which 38 % of all patients were included
2016 | Year | 07 | Month | 15 | Day |
2016 | Year | 07 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026734